98%
921
2 minutes
20
Objectives: This study investigated the optimal timing for percutaneous coronary intervention (PCI) in patients with NSTEMI complicated by heart failure (HF).
Methods: In total, 762 patients with NSTEMI and HF in a multicenter, prospective registry in South Korea were classified according to the Killip classification (Killip class 2, n = 414 and Killip class 3, n = 348) and underwent early (within 24 h) and delayed (after 24 h) PCI. The primary outcome was all-cause mortality which was further analyzed with landmark analysis with two months as a cut-off. Secondary outcomes were cardiovascular death, in-hospital cardiogenic shock (CS), readmission due to HF, and acute myocardial infarction during follow-up.
Results: Delayed PCI was associated with lower rates of 2-month mortality (6.1 % vs. 15.8 %, p = 0.007) and in-hospital CS (4.3 % vs. 14.1 %, p = 0.003), along with lower risks of 2-month mortality (hazard ratio [HR] = 0.38, 95 % confidence interval [CI] = 0.18-0.83, p = 0.014), in-hospital CS (HR = 0.29, 95 % CI = 0.12-0.71, p = 0.006) in multivariate Cox models of Killip class 3 patients. There was no statistical difference of incidence and risk of all predefined outcomes according to varying timing of PCI in Killip 2 patients.
Conclusions: Based on these results, the timing of PCI in patients with NSTEMI complicated by HF should be determined based on HF severity. Delayed PCI should be considered in patients with NSTEMI and more severe HF.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.carrev.2024.04.295 | DOI Listing |
J Neurosurg Anesthesiol
October 2025
Department of Anesthesiology and Perioperative Medicine, Thomas Jefferson University, Philadelphia, PA.
Background: Acute postoperative hypertension (APH) is encountered in patients following craniotomy and is associated with major complications. This retrospective cohort study evaluates 30-day survival for patients who received labetalol, nicardipine, or both drugs.
Methods: Patients 18 and older who underwent craniotomy between January 1, 2010 and January 1, 2023 were included in the study.
Front Cardiovasc Med
August 2025
Departments of Cardiology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Objective: This study aims to investigate the relation of inflammatory markers to the long-term prognosis of patients with severe non-ST-segment elevation myocardial infarction (NSTEMI) in the intensive care unit (ICU), and to further develop a predictive model for their long-term outcomes.
Methods: This study utilized data on eligible NSTEMI patients from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Patients were grouped based on mortality outcomes.
PLoS One
September 2025
Cardiovascular Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Background: There is emerging evidence suggesting that vitamin D and fibrinogen play contrasting roles in ACS pathophysiology and their combined impact, expressed as the vitamin D/fibrinogen ratio, can be a potential biomarker for ACS severity. This study aimed to investigate the relationship between vitamin D, fibrinogen, and their ratio with ACS types, and assess their potential as risk stratification biomarkers.
Methods: This multicenter observational study was conducted in tertiary care hospitals in Afghanistan, Egypt, and Pakistan, including 300 ACS patients.
Front Cardiovasc Med
August 2025
Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Milan, Italy.
For patients presenting with Non-ST-Elevation Myocardial Infarction (NSTEMI), the choice and timing of revascularization remain complex and debated. This decision is influenced by clinical factors such as hemodynamic stability, comorbidities and surgical risk profile, as well as anatomical considerations like coronary lesion complexity and feasibility of achieving complete revascularization. Randomized controlled trials directly comparing CABG and PCI in NSTEMI are limited, making evidence-based comparisons challenging.
View Article and Find Full Text PDFJ Cardiovasc Transl Res
September 2025
Instituto de Investigación Sanitaria Hospital Universitario 12 de Octubre (I+12 Institute), Madrid, Spain.
Neutrophil extracellular traps (NETs) are implicated in thrombosis and inflammation during acute myocardial infarction (AMI), but their kinetics, local distribution, and clinical relevance remain unclear. We conducted a prospective study in 144 patients with ST-segment elevation (STEMI) and non-ST-segment elevation AMI (NSTEMI) undergoing coronary angioplasty (PCI), quantifying double-stranded DNA (dsDNA), myeloperoxidase (MPO), and neutrophil elastase (NE) in the infarct-related artery (IRA), contralateral coronary artery (CCA), and peripheral blood. Coronary thrombi and DNASE1 Q222R were also analysed.
View Article and Find Full Text PDF